-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PrcDLix72vyhoySMG875z1iqLuQBBn24CgU1XzPlh5o8HKhDuyFiT+PZvfnMu7EO sWO8qT1p+EbZtoARdtsfdA== 0001140361-10-050291.txt : 20101217 0001140361-10-050291.hdr.sgml : 20101217 20101217162532 ACCESSION NUMBER: 0001140361-10-050291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101213 FILED AS OF DATE: 20101217 DATE AS OF CHANGE: 20101217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bollon Arthur CENTRAL INDEX KEY: 0001329091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51334 FILM NUMBER: 101260184 MAIL ADDRESS: STREET 1: 13227 CEDAR LANE CITY: DALLAS STATE: TX ZIP: 75234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMOBIOTECH, INC. CENTRAL INDEX KEY: 0001301348 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330995817 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 BROADWAY STREET 2: SUITE 505 CITY: LUBBOCK STATE: TX ZIP: 79401 BUSINESS PHONE: 806 792-4608 MAIL ADDRESS: STREET 1: 1500 BROADWAY STREET 2: SUITE 505 CITY: LUBBOCK STATE: TX ZIP: 79401 FORMER COMPANY: FORMER CONFORMED NAME: HEMOBIOTECH INC DATE OF NAME CHANGE: 20040824 4 1 doc1.xml FORM 4 X0303 4 2010-12-13 0 0001301348 HEMOBIOTECH, INC. HMBT.OB 0001329091 Bollon Arthur C/O HEMOBIOTECH, INC. 1500 BROADWAY STE 505 LUBBOCK TX 79401 1 0 0 0 Options to Purchase Common Stock 0.25 2009-10-31 4 A 0 96000 0 A 2009-10-31 2014-10-31 Common Stock 96000 196000 D Options to Purchase Common Stock 0.40 2009-11-30 4 A 0 26000 0 A 2009-11-30 2014-11-30 Common Stock 26000 222000 D Options to Purchase Common Stock 0.50 2009-12-31 4 A 0 21000 0 A 2009-12-31 2014-12-31 Common Stock 21000 243000 D Options to Purchase Common Stock 0.30 2010-09-30 4 A 0 7000 0 A 2010-09-30 2015-09-30 Common Stock 7000 250000 D Options to Purchase Common Stock 0.30 2010-09-30 4 A 0 19000 0 A 2010-09-30 2015-09-30 Common Stock 19000 269000 D From October 31, 2009 through December 2009, additional options were granted in lieu of monthly salaries. On November 18, 2010, the board of directors of HemoBioTech, Inc. agreed to reprice all options to $.25. The Options to Purchase Common Stock were granted on October 31, 2009. All Options are immediately vested and exercisable upon issuance. The Options to Purchase Common Stock were granted on November 30, 2009. All Options are immediately vested and exercisable upon issuance. The Options to Purchase Common Stock were granted on December 31, 2009. All Options are immediately vested and exercisable upon issuance. The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance. The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance. /s/ Arthur P. Bollon 2010-12-13 -----END PRIVACY-ENHANCED MESSAGE-----